Target intelligence / Profile preview

Chemoreceptor trigger zone of medulla oblongata (CTZ)

Target
CTZ
Molecular classification
Neuroanatomical zone comprising multiple receptor types, Dopamine receptor family (D2), Serotonin receptor family (5-HT3), Neurokinin 1 receptor (NK-1), Histamine H1 receptor, Acetylcholine receptor, Opioid receptor
01

Overview

The Chemoreceptor trigger zone of the medulla oblongata is a small, specialized neuroanatomical area located within the area postrema on the floor of the fourth ventricle, outside the blood-brain barrier[2][3][1]. It is highly vascularized and populated by various cell types, including astrocytes and neurons with direct access to blood-borne substances[1]. Its primary function is to detect toxins and drugs circulating in the blood and cerebrospinal fluid and relay emetogenic signals to the adjacent vomiting center, initiating the physical act of vomiting. The CTZ contains multiple neurotransmitter receptors (including dopamine D2, serotonin 5-HT3, histamine H1, acetylcholine, substance P (NK-1), and opioid receptors), which are the targets of antiemetic drugs. This system serves as a crucial protective mechanism to expel potentially harmful substances before they can exert systemic toxicity[2][3][5][1].

Other names
Chemoreceptor trigger zoneCTZarea postremacentral emetic chemoreceptor apparatus
02

Mechanism of action

Blockade of neurotransmitter receptors in the CTZ (D2, 5-HT3, NK-1, H1, muscarinic receptors); Inhibition of signal relay to vomiting center, thereby preventing coordinated emetic motor response.

03

Biological functions

Detection of blood-borne toxins and emetogenic drugsInitiation of emetic (vomiting) reflexCoordination with vomiting center for protective expulsion responses
04

Disease associations

Nausea and vomiting associated with various causes (chemotherapy, opioid therapy, toxins)Motion sickness (though partly mediated outside CTZ)Adverse drug reactions involving emesis
05

Safety considerations

Drugs acting on CTZ may cause central nervous system side effects (sedation, extrapyramidal symptoms)Challenges in selectively targeting CTZ without affecting other brain regions
06

Interacting drugs

Dopamine antagonists (e.g., metoclopramide, prochlorperazine)

5 more in the full profile.

07

Biomarkers

None established for patient selectionFunctional response (e.g., absence or reduction of emesis) serves as a clinical measure of efficacy

Beyond the preview

Go deeper on Chemoreceptor trigger zone of medulla oblongata (CTZ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chemoreceptor trigger zone of medulla oblongata (CTZ).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call